Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nojima

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
British Journal of Haematology|September 13, 2001
Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosusJ Nojima, H Kuratsune, E Suehisa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1993
[Multiple myeloma and adhesion molecules]S Tagawa, H Hattori, H Shibayama, et al.
Acta Haematologica|January 1, 1992
Monocytes appearing repeatedly after chemotherapies had an identical rearrangement pattern of immunoglobulin with leukemic blasts in a patient with CD13+ acute lymphoblastic leukemiaM Mizuki, S Tagawa, J Nojima, et al.
British Journal of Haematology|March 1, 1997
Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulantJ Nojima, E Suehisa, N Akita, et al.
Internal Medicine (Tokyo, Japan)|June 1, 1993
A HTLV-I carrier who showed various symptoms and antibodies of autoimmune diseasesM Mizuki, S Tagawa, M Shibano, et al.
Leukemia|October 1, 1990
Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA)H Kuratsune, M K Owada, Y Tokumine, et al.
American Journal of Hematology|May 20, 1998
High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulantJ Nojima, E Suehisa, H Kuratsune, et al.
Leukemia|April 29, 1998
Phenotypical heterogeneity of CD4+CD8+ double-positive chronic T lymphoid leukemiaM Mizuki, S Tagawa, T Machii, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
British Journal of Haematology|September 13, 2001
Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosusJ Nojima, H Kuratsune, E Suehisa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1993
[Multiple myeloma and adhesion molecules]S Tagawa, H Hattori, H Shibayama, et al.
Acta Haematologica|January 1, 1992
Monocytes appearing repeatedly after chemotherapies had an identical rearrangement pattern of immunoglobulin with leukemic blasts in a patient with CD13+ acute lymphoblastic leukemiaM Mizuki, S Tagawa, J Nojima, et al.
British Journal of Haematology|March 1, 1997
Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulantJ Nojima, E Suehisa, N Akita, et al.
Internal Medicine (Tokyo, Japan)|June 1, 1993
A HTLV-I carrier who showed various symptoms and antibodies of autoimmune diseasesM Mizuki, S Tagawa, M Shibano, et al.
Leukemia|October 1, 1990
Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA)H Kuratsune, M K Owada, Y Tokumine, et al.
American Journal of Hematology|May 20, 1998
High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulantJ Nojima, E Suehisa, H Kuratsune, et al.
Leukemia|April 29, 1998
Phenotypical heterogeneity of CD4+CD8+ double-positive chronic T lymphoid leukemiaM Mizuki, S Tagawa, T Machii, et al.
Pageof 2